Icaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma

NCT06825546 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Advanced Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: Icaritin
DRUG: AG chemotherapy

Sponsor

Sir Run Run Shaw Hospital